rss
J Neurol Neurosurg Psychiatry 2006;77:863-867 doi:10.1136/jnnp.2005.081539
  • Paper

Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage

  1. C J M Frijns1,
  2. K M Kasius2,
  3. A Algra3,
  4. R Fijnheer2,
  5. G J E Rinkel1
  1. 1Department of Neurology, University Medical Centre Utrecht, Utrecht, The Netherlands
  2. 2Department of Haematology, Research Laboratory, University Medical Centre Utrecht
  3. 3Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht
  1. Correspondence to:
 Dr C J M Frijns
 Department of Neurology, G03.228, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands; C.J.M.Frijns{at}umcutrecht.nl
  • Received 5 October 2005
  • Accepted 15 March 2006
  • Revised 13 March 2006
  • Published Online First 30 March 2006

Abstract

Background: Endothelial cell activation may be connected with the pathogenesis of delayed cerebral ischaemia (DCI) after subarachnoid haemorrhage (SAH).

Aim: To assess the relationship between serial concentrations of circulating markers of endothelial cell activation (soluble intercellular adhesion molecule-1, soluble platelet selectin (sP-selectin), soluble endothelial selectin, ED1-fibronectin, Von Willebrand Factor (VWF) and VWF propeptide) and development of DCI.

Methods: 687 blood samples were collected from 106 consecutive patients admitted within 72 h after onset of SAH. Changes in levels were analysed in the last sample before and in the first sample after the onset of DCI (n = 30), and in subgroups with DCI occurring within 24 h after treatment of the aneurysm (n = 12) or unrelated to treatment of the aneurysm (n = 18). Patients without DCI (n = 56) served as controls.

Results: Concentrations of sP-selectin, but not of the other markers, were found to increase considerably after DCI unrelated to treatment of the aneurysm (increase 25 ng/ml, 95% CI 8 to 43), whereas they tended to decrease in the control patients without DCI (decrease 13 ng/ml, 95% CI −28 to 2.4). Surgery was found to profoundly influence the levels of the markers irrespective of the occurrence of DCI.

Conclusion: The rise in sP-selectin level during DCI is suggested to be the result of platelet activation, as levels of the other markers of endothelial cell activation were not increased after DCI unrelated to treatment. Whether a causal role of platelet activation is implicated in the development of DCI should be determined in further studies in which the relationship between concentrations of markers and treatment is taken into account.

Footnotes

  • Published Online First 30 March 2006

  • Competing interests: None.

  • Ethical approval: The institutional review board approved the study.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs